Abstract
Tissue Engineering of skeletal muscle tissue still remains a major challenge. Every neo-tissue construct of clinically relevant dimensions is highly dependent on an intrinsic vascularisation overcoming the limitations of diffusion conditioned survival. Approaches incorporating the arteriovenous-loop model might bring further advances to the generation of vascularised skeletal muscle tissue. In this study 12 syngeneic rats received transplantation of carboxy-fluorescine diacetate-succinimidyl ester (CFDA)-labelled, expanded primary myoblasts into a previously vascularised fibrin matrix, containing a microsurgically created AV loop. As control cells were injected into fibrin-matrices without AV-loops. Intra-arterial ink injection followed by explantation was performed 2, 4 and 8 weeks after cell implantation. Specimens were evaluated for CFDA, MyoD and DAPI staining, as well as for mRNA expression of muscle specific genes. Results showed enhanced fibrin resorption in dependence of AV loop presence. Transplanted myoblasts could be detected in the AV loop group even after 8 weeks by CFDA-fluorescence, still showing positive MyoD staining. RT-PCR revealed gene expression of MEF-2 and desmin after 4 weeks on the AV loop side, whereas expression analysis of myogenin and MHCembryo was negative. So far myoblast injection in the microsurgical rat AV loop model enhances survival of the cells, keeping their myogenic phenotype, within pre-vascularised fibrin matrices. Probably due to the lack of potent myogenic stimuli and additionally the rapid resorption of the fibrin matrix, no formation of skeletal muscle-like tissue could be observed. Thus further studies focussing on long term stability of the matrix and the incorporation of neural stimuli will be necessary for generation of vascularised skeletal muscle tissue.
Keywords: tissue engineering, myoblasts, skeletal muscle, vascularisation, arteriovenous loop
References
- 1.Blau HM, Webster C. Isolaition and characterization of human muscle cells. Proc Natl Acad Sci USA. 1981;78:5623–7. doi: 10.1073/pnas.78.9.5623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Blanco-Bose WE, Yao CC, Kramer RH, Blau HM. Purification of mouse primary myoblasts based on alpha 7 integrin expression. Exp Cell Res. 2001;265:212–20. doi: 10.1006/excr.2001.5191. [DOI] [PubMed] [Google Scholar]
- 3.Kosnik PE, Faulkner JA, Dennis RG. Functional development of engineered skeletal muscle from adult and neonatal rats. Tissue Eng. 2001;7:573–84. doi: 10.1089/107632701753213192. [DOI] [PubMed] [Google Scholar]
- 4.Neumann T, Hauschka SD, Sanders JE. Tissue engineering of skeletal muscle using polymer fiber arrays. Tissue Eng. 2003;9:995–1003. doi: 10.1089/107632703322495637. [DOI] [PubMed] [Google Scholar]
- 5.Kneser U, Polykandriotis E, Ohnolz J, Heidner K, Grabinger L, Euler S, Amann KU, Hess A, Brune K, Greil P, Stürzl M, Horch RE. 2006. Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop Tissue Eng ; in press. [DOI] [PubMed]
- 6.Bach AD, Beier JP, Stark GB. Expression of Trisk 51, agrin and nicotinic-acetycholine receptor epsilon-subunit during muscle development in a novel three-dimensional muscle-neuronal co-culture system. Cell Tissue Res. 2003;314:263–74. doi: 10.1007/s00441-003-0757-6. [DOI] [PubMed] [Google Scholar]
- 7.Bach AD, Beier JP, Stern-Staeter J, Horch RE. Skeletal muscle tissue engineering. J Cell Mol Med. 2004;8:413–22. doi: 10.1111/j.1582-4934.2004.tb00466.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Bach AD, Stem-Straeter J, Beier JP, Bannasch H, Stark GB. Engineering of muscle tissue. Clin Plast Surg. 2003;30:589–99. doi: 10.1016/s0094-1298(03)00077-4. [DOI] [PubMed] [Google Scholar]
- 9.Levenberg S, Rouwkema J, Macdonald M, Garfein ES, Kohane DS, Darland DC, Marini R, van Blitterswijk CA, Mulligan RC, D’Amore PA, Langer R. Engineering vascularized skeletal muscle tissue. Nat Biotechnol. 2005;23:879–84. doi: 10.1038/nbt1109. [DOI] [PubMed] [Google Scholar]
- 10.Messina A, Bortolotto SK, Cassell OC, Kelly J, Abberton KM, Morrison WA. Generation of a vascularized organoid using skeletal muscle as the inductive source. FASEB J. 2005;19:1570–2. doi: 10.1096/fj.04-3241fje. [DOI] [PubMed] [Google Scholar]
- 11.Cassell OC, Morrison WA, Messina A, Penington AJ, Thompson EW, Stevens GW, Perera JM, Kleinman HK, Hurley JV, Romeo R, Knight KR. The influence of extracellular matrix on the generation of vascularized, engineered, transplantable tissue. Ann N Y Acad Sci. 2001;944:429–42. doi: 10.1111/j.1749-6632.2001.tb03853.x. [DOI] [PubMed] [Google Scholar]
- 12.Cao Y, Mitchell G, Messina A, Price L, Thompson E, Penington A, Morrison W, O’Connor A, Stevens G, Cooper-White J. The influence of architecture on degradation and tissue ingrowth into three-dimensional poly(lactic-co-glycolic acid) scaffolds in vitro and in vivo. Biomaterials. 2006;27:2854–64. doi: 10.1016/j.biomaterials.2005.12.015. [DOI] [PubMed] [Google Scholar]
- 13.Birla RK, Borschel GH, Dennis RG, Brown DL. Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng. 2005;11:803–13. doi: 10.1089/ten.2005.11.803. [DOI] [PubMed] [Google Scholar]
- 14.Stern-Straeter J, Bach A, Stangenberg L, Foerster V, Horch RE, Stark GB, Beier JP. Impact of electrical stimulation on three-dimensional myoblast cultures - a real-time RT-PCR study. J Cell Mol Med. 2005;9:883–92. doi: 10.1111/j.1582-4934.2005.tb00386.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bach AD, Bannasch H, Galla TJ, Bittner KM, Stark GB. Fibrin glue as matrix for cultured autologous urothelial cells in urethral reconstruction. Tissue Eng. 2001;7:45–53. doi: 10.1089/107632701300003287. [DOI] [PubMed] [Google Scholar]
- 16.Erol OO, Spira M. New capillary bed formation with a surgically constructed arteriovenous fistula. Plast Reconstr Surg. 1980;66:109–15. doi: 10.1097/00006534-198007000-00021. [DOI] [PubMed] [Google Scholar]
- 17.Mian R, Morrison WA, Hurley JV, Penington AJ, Romeo R, Tanaka Y, Knight KR. Formation of new tissue from an arteriovenous loop in the absence of added extracellular matrix. Tissue Eng. 2000;6:595–603. doi: 10.1089/10763270050199541. [DOI] [PubMed] [Google Scholar]
- 18.Tanaka Y, Sung KC, Tsutsumi A, Ohba S, Ueda K, Morrison WA. Tissue engineering skin flaps: which vascular carrier, arteriovenous shunt loop or arteriovenous bundle, has more potential for angiogenesis and tissue generation. Plast Reconstr Surg. 2003;112:1636–44. doi: 10.1097/01.PRS.0000086140.49022.AB. [DOI] [PubMed] [Google Scholar]
- 19.Beier JP, Kneser U, Stern-Strater J, Stark GB, Bach AD. Y chromosome detection of three-dimensional tissueengineered skeletal muscle constructs in a syngeneic rat animal model. Cell Transplant. 2004;13:45–53. doi: 10.3727/000000004772664888. [DOI] [PubMed] [Google Scholar]
- 20.Riquelme C, Barthel KK, Liu X. SUMO-1 modification of MEF2A regulates its transcriptional activity. J Cell Mol Med. 2006;10:132–44. doi: 10.1111/j.1582-4934.2006.tb00295.x. [DOI] [PMC free article] [PubMed] [Google Scholar]